FMD Case Studies

FMD Case Studies

NHS Digital have collected case studies to demonstrate how Community and Hospital Pharmacies have implemented the FMD. They show how the new processes have been put into practice, what software and hardware were required, training and communication requirements, and hints and tips for other Pharmacies.

Community Pharmacy FMD case studies
FMD case study – Ben Eaton, Dean and Smedley
We visited Ben Eaton at the Dean and Smedley Pharmacy he manages in Swadlincote, Derby in February 2019, five days after the Falsified Medicines Directive (FMD) became law, to talk with him about his experiences so far

FMD case study – David Broome, Stancliffe Pharmacy, Bramhope
We visited pharmacist David Broome at his pharmacy in the village of Bramhope, North Leeds in February 2019, four days after the Falsified Medicines Directive (FMD) became law, and two weeks after he first activated FMD scanning.

FMD case study – Kerry Welch, Weldricks Pharmacy
We visited pharmacist Kerry Welch at Weldricks Pharmacy, Field Road, Stainforth, one of 64 Weldricks community pharmacies located in the Doncaster area.

FMD case study – Robert Vaughan, Lincolnshire Coop Pharmacy
The Coop Pharmacy group has 49 branches across Lincolnshire, Nottinghamshire and Norfolk. The branch we visited in Lincoln Was one of the first to go live with the Falsified Medicines Directive (FMD) in November 2018. We met with area manager Robert Vaughan in March 2019 for a chat about how they introduced FMD to their branches.

Secondary care FMD case studies
FMD case study – Aintree University Hospital
Alex Jennings is Deputy Chief Pharmacist at Aintree University Hospital NHS Foundation Trust in Liverpool. He has developed standalone software for the Falsified Medicines Directive (FMD) in his spare time and currently more than 40 hospitals and five community pharmacy chains are using it. We visited him in February 2019.

FMD case study – Darlington Memorial Hospital
We visited Dan Hibell, Informatics Lead Pharmacist at Darlington Memorial Hospital (part of County Durham and Darlington NHS Foundation Trust), in February 2019, a few days after FMD became law. Darlington was one of the initial pilot sites for FMD implementation and was one of several trusts that helped NHS Digital produce a toolkit to support others in implementing FMD.

Related articles

EU Exit and UK MVS

The United Kingdom Transition Period ended on 31st December 2020 and the UK became a third country in relation to the EU.

Where can I find a copy of the Delegated Regulation?

You can find the Delegated Regulation here.

Which medicines are in scope of FMD?

For details of the scope of the regulation please check: FMD Delegated Regulation 2016_161

Where stakeholders are unclear on the legislation, for example whether types of medicine are in/out of scope, please contact DHSC/MHRA at fmd. safetyfeatures@mhra. gov. uk.

Will anti-tamper devices be allowed on OTCs and other out-of-scope products after February 2019?

The MHRA has confirmed that subject to the outcome of a public consultation anti-tamper devices may continue to be placed on out-of-scope products after 9th February 2019 if the relevant manufacturer considers that it is necessary to do so in the interests of patient safety.

If you have independent subsidiaries across one hospital trust, does each subsidiary need to be registered separately to the hospital in which it is located?

Please check which location(s) are registered with the relevant professional or sectoral body (such as PSNI). SecurMed will provide individual credentials for each Location that is individually registered with the relevant body.